Topic · Liver Diseases and Immunity
Most cited papers in Liver Diseases and Immunity
What are the most cited papers in Liver Diseases and Immunity?
The most cited paper in Liver Diseases and Immunity is "Histological grading and staging of chronic hepatitis" (Kamal G. Ishak, Amélia Baptista, Leonardo Bianchi et al., 1995), with 5,081 citations. Next come "An Algorithm for the Grading of Activity in Chronic Hepatitis C" (4,058) and "Burden of liver diseases in the world" (3,840).
Showing 50 of 100 papers. Every paper with more than 855 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Histological grading and staging of chronic hepatitis Kamal G. Ishak, Amélia Baptista, Leonardo Bianchi et al. · Journal of Hepatology | Jun 1995 | 5,081 |
| 2 | An Algorithm for the Grading of Activity in Chronic Hepatitis C Pierre Bédossa, Thierry Poynard · Hepatology | Aug 1996 | 4,058 |
| 3 | Burden of liver diseases in the world Sumeet K. Asrani, Harshad C. Devarbhavi, John E. Eaton et al. · Journal of Hepatology | 25 Sep 2018 | 3,840 |
| 4 | Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis† Robert G. Knodell, Kamal G. Ishak, William C. Black et al. · Hepatology | Sep 1981 | 3,575 |
| 5 | Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C John G. McHutchison, Stuart C. Gordon, Eugene R. Schiff et al. · New England Journal of Medicine | 19 Nov 1998 | 3,509 |
| 6 | Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity☆, ☆☆ Christi A Matteoni, Zobair M. Younossi, T GRAMLICH et al. · Gastroenterology | Jun 1999 | 3,376 |
| 7 | Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative Colitis Kenneth W. Schroeder, William J. Tremaine, Duane M. Ilstrup · New England Journal of Medicine | 24 Dec 1987 | 3,069 |
| 8 | International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis Fernando Villar Álvarez et al. · Journal of Hepatology | Nov 1999 | 2,928 |
| 9 | Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis Brian G. Feagan, Paul J. Rutgeerts, Bruce E. Sands et al. · New England Journal of Medicine | 21 Aug 2013 | 2,910 |
| 10 | Development of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus Melissa R. Arbuckle, Micah T. McClain, Mark V. Rubertone et al. · New England Journal of Medicine | 15 Oct 2003 | 2,612 |
| 11 | Classification of chronic hepatitis: Diagnosis, grading and staging Valeer J. Desmet, Michael A. Gerber, Jay H. Hoofnagle et al. · Hepatology | Jun 1994 | 2,578 |
| 12 | Model for end-stage liver disease (MELD) and allocation of donor livers Russell H. Wiesner, Erick Edwards, Richard B. Freeman et al. · Gastroenterology | 2003 | 2,549 |
| 13 | Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis Eduardo Vilar‐Gómez, Yadina Martínez-Pérez, Luis Calzadilla Bertot et al. · Gastroenterology | 10 Apr 2015 | 2,487 |
| 14 | Dichotomizing continuous predictors in multiple regression: a bad idea Patrick J Royston, Douglas G. Altman, Willi Sauerbrei · Statistics in Medicine | 11 Oct 2005 | 2,319 |
| 15 | Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial Brent A. Neuschwander‐Tetri, Rohit Seth Loomba, Arun Jayant Sanyal et al. · The Lancet | 6 Nov 2014 | 2,226 |
| 16 | Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease Vlad Ratziu, Frédéric Charlotte, A. Heurtier et al. · Gastroenterology | Jun 2005 | 2,108 |
| 17 | A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis Stephen A. Harrison et al. · New England Journal of Medicine | 7 Feb 2024 | 1,963 |
| 18 | Simplified criteria for the diagnosis of autoimmune hepatitis† Elke M. Hennes, Mikio Zeniya, Albert J. Czaja et al. · Hepatology | 19 Mar 2008 | 1,907 |
| 19 | Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Zobair M. Younossi, Frank Tacke, Marco A. Arrese et al. · Hepatology | 4 Sep 2018 | 1,898 |
| 20 | EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 update Annalisa Berzigotti, Emmanouil Tsochatzis, Jérôme Boursier et al. · Journal of Hepatology | 21 Jun 2021 | 1,887 |
| 21 | Dysplasia in inflammatory bowel disease: Standardized classification with provisional clinical applications Robert H. Riddell, Harvey S. Goldman, David F. Ransohoff et al. · Human Pathology | Nov 1983 | 1,879 |
| 22 | Specific autoantibodies precede the symptoms of rheumatoid arthritis: A study of serial measurements in blood donors Markus M. J. Nielen, Dirkjan van Schaardenburg, Henk W. Reesink et al. · Arthritis & Rheumatism | Feb 2004 | 1,868 |
| 23 | Liver fibrosis – from bench to bedside Scott L. Friedman · Journal of Hepatology | 2003 | 1,794 |
| 24 | Cyclosporine in Severe Ulcerative Colitis Refractory to Steroid Therapy Simon Lichtiger, Daniel H. Present, Asher A. Kornbluth et al. · New England Journal of Medicine | 30 Jun 1994 | 1,746 |
| 25 | A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus Richard Alan Furie, Michelle Petri, Omid Zamani et al. · Arthritis & Rheumatism | Sep 2011 | 1,693 |
| 26 | The global NAFLD epidemic Rohit Seth Loomba, Arun Jayant Sanyal · Nature Reviews Gastroenterology & Hepatology | 17 Sep 2013 | 1,670 |
| 27 | The Natural History of Community-Acquired Hepatitis C in the United States Miriam J. Alter, Harold S. Margolis, Krzysztof Krawczynski et al. · New England Journal of Medicine | 31 Dec 1992 | 1,615 |
| 28 | Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis Paul Angulo, Jill C. Keach, Kenneth P. Batts et al. · Hepatology | Dec 1999 | 1,615 |
| 29 | The burden of selected digestive diseases in the United States Robert S. Sandler, James E. Everhart, Mark Donowitz et al. · Gastroenterology | May 2002 | 1,527 |
| 30 | EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis Gideon Morris Hirschfield, Ulrich H. Beuers, Christophe Corpechot et al. · Journal of Hepatology | 18 Apr 2017 | 1,500 |
| 31 | American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis Bevra Hannahs Hahn et al. · Arthritis Care & Research | 3 May 2012 | 1,494 |
| 32 | Prevalence of Fatty Liver in Children and Adolescents Jeffrey B. Schwimmer, Reena Deutsch, Tanaz Kahen et al. · PEDIATRICS | Oct 2006 | 1,485 |
| 33 | Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C Marianne Ziol, Adriana Handra‐Luca, A. Kettaneh et al. · Hepatology | 23 Dec 2004 | 1,475 |
| 34 | Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study Brad H. Rovin, Richard Alan Furie, Kevin M. Latinis et al. · Arthritis & Rheumatism | 9 Jan 2012 | 1,470 |
| 35 | Guidelines for the management of inflammatory bowel disease in adults Craig Mowat, Andrew Cole, Alastair C. J. Windsor et al. · Gut | 4 Apr 2011 | 1,447 |
| 36 | Expanding the natural history of nonalcoholic steatohepatitis: From cryptogenic cirrhosis to hepatocellular carcinoma Elisabetta Bugianesi, Nicola Leone, Ester Vanni et al. · Gastroenterology | Jul 2002 | 1,443 |
| 37 | Diagnosis and Management of Autoimmune Hepatitis Michael Peter Manns, Albert J. Czaja, James D. Gorham et al. · Hepatology | 8 Feb 2010 | 1,439 |
| 38 | Non-invasive evaluation of liver fibrosis using transient elastography Laurent Castéra, Xavier Forns, Alfredo Alberti · Journal of Hepatology | 11 Mar 2008 | 1,436 |
| 39 | Chronic pancreatitis caused by an autoimmune abnormality Kenji Yoshida, Fumitake Toki, Tadashi Takeuchi et al. · Digestive Diseases and Sciences | Jul 1995 | 1,434 |
| 40 | Efficacy and safety of rituximab in moderately‐to‐severely active systemic lupus erythematosus: The randomized, double‐blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial Joan T. Merrill, C. Michael Neuwelt, Daniel J. Wallace et al. · Arthritis & Rheumatism | 28 Dec 2009 | 1,419 |
| 41 | ESPGHAN Revised Porto Criteria for the Diagnosis of Inflammatory Bowel Disease in Children and Adolescents Arie Levine, Sibylle Koletzko, Dan Turner et al. · Journal of Pediatric Gastroenterology and Nutrition | 14 Nov 2013 | 1,416 |
| 42 | Bile acids and the gut microbiome Jason Michael Ridlon, Dae J. Kang, Phillip B. Hylemon et al. · Current Opinion in Gastroenterology | 13 Mar 2014 | 1,361 |
| 43 | Hepatitis E Virus and Chronic Hepatitis in Organ-Transplant Recipients Nassim Kamar, Janick Sèlves, Jean‐Michel Mansuy et al. · New England Journal of Medicine | 20 Feb 2008 | 1,353 |
| 44 | Cholangiocarcinoma Michelle Lucinda DeOliveira, Steven Clark Cunningham, John L. Cameron et al. · Annals of Surgery | 20 Apr 2007 | 1,311 |
| 45 | Interferon Alfa-2b Alone or in Combination with Ribavirin for the Treatment of Relapse of Chronic Hepatitis C Gary L. Davis, Rafael Esteban, Vinod K. Rustgi et al. · New England Journal of Medicine | 19 Nov 1998 | 1,299 |
| 46 | A Role for Hepatitis C Virus Infection in Type II Cryoglobulinemia Vincent Agnello, Raymond T. Chung, Lee M. Kaplan · New England Journal of Medicine | 19 Nov 1992 | 1,298 |
| 47 | Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis William J. Sandborn, Gert Van Assche, Walter Reinisch et al. · Gastroenterology | 5 Nov 2011 | 1,274 |
| 48 | Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial Zobair M. Younossi et al. · The Lancet | Dec 2019 | 1,260 |
| 49 | Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis Matthew D. Rutter, Brian P. Saunders, Kay H. Wilkinson et al. · Gastroenterology | Feb 2004 | 1,257 |
| 50 | Nonalcoholic Fatty Liver Disease 2020: The State of the Disease Thomas Gerard Cotter, Mary Eugenia Rinella · Gastroenterology | 12 Feb 2020 | 1,244 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.